Serial Number | 97097081 |
Word Mark | TCR2 THERAPEUTICS |
Filing Date | Thursday, October 28, 2021 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, December 11, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, September 13, 2022 |
Description of Mark | The mark consists of the stylized letters TCR and stylized number 2 above the stylized word THERAPEUTICS. |
Goods and Services | Pharmaceutical preparations, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use, namely, biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases |
Pseudo Mark | TCR TWO THERAPEUTICS |
Disclaimer with Predetermined Text | "TCR" and "THERAPEUTICS" |
Goods and Services | Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, August 10, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, November 9, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | TCR2 Therapeutics Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02142 |
Party Name | TCR2 Therapeutics Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02142 |
Event Date | Event Description |
Monday, December 11, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, December 11, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
Thursday, April 6, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, April 4, 2023 | SOU EXTENSION 1 GRANTED |
Tuesday, April 4, 2023 | SOU EXTENSION 1 FILED |
Tuesday, April 4, 2023 | SOU TEAS EXTENSION RECEIVED |
Tuesday, November 8, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, September 13, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, September 13, 2022 | PUBLISHED FOR OPPOSITION |
Wednesday, August 24, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, August 10, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, August 10, 2022 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, August 10, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, August 10, 2022 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, August 10, 2022 | EXAMINERS AMENDMENT -WRITTEN |
Monday, August 8, 2022 | ASSIGNED TO EXAMINER |
Tuesday, November 9, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, November 1, 2021 | NEW APPLICATION ENTERED |